Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$136.06 USD
+1.81 (1.35%)
Updated Oct 17, 2025 04:00 PM ET
After-Market: $136.03 -0.03 (-0.02%) 6:46 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Jazz Pharmaceuticals PLC's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
JAZZ 136.06 +1.81(1.35%)
Will JAZZ be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for JAZZ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JAZZ
Roche Wins FDA Nod for Label Expansion of Tecentriq in Lung Cancer
Can Auvelity Drive Axsome's Growth Through the Rest of 2025?
JAZZ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why JAZZ Stock Is an Unconventional Cannabis Investment
Axsome Shares Up 20% in a Month: How Should You Play the Stock?
JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug
Other News for JAZZ
3 Small Cap Stocks To Play As The Bantamweights Break Out On Wall Street
First Week of June 2026 Options Trading For Jazz Pharmaceuticals (JAZZ)
JAZZ falls 1.14% on October 16, leaving the technical picture intact
Jazz Pharmaceuticals Completes Study on Promising HER2 Cancer Treatment
Is JAZZ positioned for a breakout? 20 Day Moving Average Support shows up after climbing 1.49%